French Biotech Stock News

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

With a price-to-earnings (or "P/E") ratio of 52.3x EssilorLuxottica Société anonyme ( EPA:EL ) may be sending very...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Bharti Space Limited’s purchase of 88.7 million Eutelsat Communications (ENXTPA:ETL) shares on 16 December is a big governance moment, tightening its grip on the satellite operator’s future direction. See our latest analysis for Eutelsat Communications. That move comes after a bruising stretch for investors, with a 30 day share price return of minus 47.1 percent and a five year total shareholder return of minus 72.1 percent. As a result, any sign of strategic conviction now looks like an...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Nexans S.A. ( EPA:NEX ), might not be a large cap stock, but it received a lot of attention from a substantial price...

Key Insights Given the large stake in the stock by institutions, Alten's stock price might be vulnerable to their...

Veolia Environnement SA ( EPA:VIE ) saw its share price hover around a small range of €28.40 to €29.97 over the last...

Wondering if Publicis Groupe is quietly turning into a value opportunity, or if the market has already priced in the upside? The stock has edged up about 1.5% over the last week and 5.5% over the past month, even though it is still down roughly 13.9% year to date and 10.2% over the last year after a very strong 3 and 5 year run. Recent headlines have focused on Publicis tightening its focus on high margin data and tech led services and securing new global client mandates, reinforcing its...

If you are wondering whether Atos at around €46 is a turnaround bargain or a value trap, you are not the only one. That is exactly what this breakdown is going to tackle. The stock has swung hard lately, down 15.9% over the last week but still up 6.0% over 30 days, with an eye catching 85.8% gain year to date and a 121.2% rise over the past year after a brutal multi year slide. Those moves come after years of restructuring and strategic shifts that have investors rethinking the long term...

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

SPIE (ENXTPA:SPIE) just deepened its relationship with Tesla through a multi year European framework agreement for battery energy storage projects, a strategic move that plugs SPIE directly into the grid scale transition story. See our latest analysis for SPIE. Those moves sit against a strong backdrop, with the share price up sharply this year on the back of the Tesla framework, energy transition acquisitions and an upcoming anti dilutive buyback, signalling building momentum and improving...

If you are wondering whether Pluxee is a beaten down opportunity or a value trap at its current price, this is a good place to unpack what the market might be missing. The stock has been choppy lately, up 1.8% over the last week but still down 4.5% over 30 days and roughly 29% lower year to date. This naturally raises questions about whether sentiment has swung too far. Recent coverage has focused on Pluxee's standalone positioning in employee benefits and engagement solutions following its...

SPIE recently announced that it has signed a renewable three‑year European framework agreement with Tesla to deliver Megapack-based battery energy storage system projects across its specialist subsidiaries, covering existing and potential work in France, Belgium, the Netherlands, Poland and Germany. This deal not only deepens SPIE’s role in the energy transition by integrating large-scale storage into power grids, it also standardises project execution and legal terms across Europe,...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Sodexo S.A...

In December 2025, Société BIC said it would discontinue Rocketbook and its Skin Creative tattoo businesses Inkbox and Tattly, winding down their operations by the first quarter of 2026 after reviewing their performance against group ambitions. This exit from digital writing and tattoo products marks a clear refocus on BIC’s core categories and a tightening of its portfolio discipline. We’ll now examine how BIC’s decision to exit Rocketbook and Skin Creative-tattoo activities reshapes its...

Rubis (EPA:RUI) has had a rough month with its share price down 2.9%. But if you pay close attention, you might gather...

If you are wondering whether Schneider Electric is still a smart buy at today’s price, or if most of the upside has already been captured, you are not alone. This article will walk through what the current market is really pricing in. Despite a strong multi year run, with the stock up roughly 121% over five years and almost 90% over three, the more recent picture has flattened out, with the share price roughly flat over 7 days and slightly negative over the last month and year to...

Egide S.A. ( EPA:ALGID ) shares have had a really impressive month, gaining 45% after a shaky period beforehand. The...

FDJ United (ENXTPA:FDJU) has quietly slipped this year, with the stock down sharply over the past 3 months and year, even as revenue and net income keep grinding higher in the background. See our latest analysis for FDJ United. That slide has come despite the company completing its rebrand to FDJ United and continuing to post steady top line and earnings growth. The year to date share price return of negative 38.09 percent has dragged longer term total shareholder returns lower and is...

Wondering if Bureau Veritas is quietly turning into a value opportunity, or if the recent share price drift is a warning sign? This article will walk you through what the numbers really say. The stock has slipped recently, down about 3.0% over the last week, 8.3% over the last month, and 10.6% year to date, but longer term holders are still sitting on gains of 15.4% over three years and 30.8% over five years. Recent headlines have focused on Bureau Veritas expanding its role in...

Sopra Steria announced that its board has appointed Rajesh Krishnamurthy as Group Chief Executive Officer, effective February 2, 2026, bringing three decades of international technology, consulting and transformation experience across Europe, Asia and the Americas. His track record in scaling Infosys and transforming Expleo, including shifting toward digital engineering and AI-enabled services, aligns closely with Sopra Steria’s ambitions in high-value, technology-led offerings. We’ll now...

In the past week, MedinCell reported stronger-than-expected H1 2026 earnings while partner Teva submitted a New Drug Application to the FDA for their jointly developed olanzapine long-acting injectable for schizophrenia, alongside progress on multiple late-stage and partnered programs. The combination of UZEDY’s performance, the FDA filing for olanzapine LAI, and new backing for pipeline assets such as the AbbVie and Gates Foundation-supported programs signals a broadening of MedinCell’s...

Eurofins Consumer Product Testing Vietnam has completed a major expansion, relocating to a purpose-built 7,000 sq. m laboratory in Ho Chi Minh City that offers more than two and a half times the floor space of its previous site. This enlarged facility underscores Eurofins’ commitment to supporting Vietnam’s growing role in global manufacturing supply chains, enhancing its ability to serve international brands, retailers, and manufacturers with broader testing capacity. Next, we’ll explore...